SERVICES

Antibody
Discovery

AbCheck engineers and provide clients with antibody candidates for therapeutic indications

Overview

AbCheck utilizes an unique combination of in vitro and in vivo technologies as sources for antibody discovery.
We use libraries of human antibodies and project-specifically humanized libraries cloned from immunized rabbits to identify
distinctive antibody sequences against our clients‘ targets.

In a tailored workflow approach, AbCheck provides a seamless and sophisticated transition between phage and yeast
display selection strategies. AbCheck provides various options for the de novo discovery of antibodies against
virtually all targets in scFv, IgG or bi-specific formats.

Our scientific expertise and technology platforms that have been refined and advanced over years, deliver a highly specific antibody for better outcomes.

Proven Scientific Expertise - Several of our antibodies are validated by leads in the clinic
Key
Components
1 Addressing of special epitope requirements and biological functions
2 High throughput of lead candidates in the final drug format
3 Isolated antibodies with sub-nanomolar affinities
4 Tailor-made workflow for every individual project
Used
Technologies


Proprietary
Libraries

Technologies

AbSieve™
Antibody
Selection

Technologies


Rabbit Mass
Humanization

Technologies
Related
Posters
Discovery and Optimization of Therapeutic Antibodies
Download PDF
AbSieve combines strength of Phage and Yeast Display for finding better drug candidates
Download PDF
Comparison of Phage and Yeast Display for Rabbit Mass Humanization
Download PDF
Mass Humanization of Rabbit Antibodies
Download PDF

Our Services

Antibody
Discovery

Services

Antibody
Optimization

Services

Our Unique Platforms

Proprietary
Libraries

Technologies

Rabbit Mass
Humanization

Technologies

AbSieve™
Antibody
Selection

Technologies

AbAccel™
Antibody
Optimization

Technologies